Marseilles, France

Pierre Edouard Bougis


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Pierre Edouard Bougis

Introduction

Pierre Edouard Bougis is a notable inventor based in Marseilles, France. He has made significant contributions to the field of biochemistry, particularly in the development of assays and therapeutic agents. With a total of two patents to his name, Bougis has demonstrated a commitment to advancing scientific knowledge and practical applications.

Latest Patents

Bougis's latest patents include a surface plasmon resonance approach to monitor protein-ligand interactions. This invention provides assays utilizing SPR to detect protein-ligand interactions, as well as the compositions used in such assays. Another significant patent is for a scorpion peptide as a hypotensive agent. This invention presents isoforms from a peptide family belonging to South American scorpions that act as hypotensive agents by potentiating Bradykinin. The peptide, initially isolated from venom, showed strong and long-lasting hypotensive activity when tested in rats. The peptide was first named TsHpt-I (Hypotensin-I), and three more highly similar isoforms were identified, named TsHpt-II, TsHpt-III, and TsHpt-IV.

Career Highlights

Throughout his career, Bougis has worked with prestigious institutions such as The Johns Hopkins University and the Centre National de la Recherche Scientifique. His work has focused on the intersection of biochemistry and pharmacology, leading to innovative solutions in the medical field.

Collaborations

Some of his notable coworkers include Marie-France Eauclaire and Frank Bosmans. Their collaborative efforts have contributed to the success of his research and inventions.

Conclusion

Pierre Edouard Bougis is a distinguished inventor whose work in biochemistry has led to significant advancements in the understanding of protein-ligand interactions and the development of hypotensive agents. His contributions continue to impact the scientific community and the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…